ORBIMED ADVISORS LLC – Vertex Pharmaceuticals Incorporated Transaction History
ORBIMED ADVISORS LLC portfolio value:
$108.05M
portfolio value
ORBIMED ADVISORS LLC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -3.62% | -14K shares | -1.05M | $289.54 | 373.2K |
| Q2 2022 | share | Decrease | -3.25% | -13K shares | 4.66M | $281.79 | 387.2K |
| Q1 2022 | share | Decrease | -39.19% | -257.9K shares | -40.07M | $260.97 | 400.2K |
| Q4 2021 | share | Decrease | -24.99% | -219.3K shares | -14.63M | $222.45 | 658.1K |
| Q3 2021 | share | Decrease | -17.65% | -188K shares | -55.66M | $181.39 | 877.4K |
| Q2 2021 | share | Decrease | -6.21% | -70.5K shares | -29.27M | $201.63 | 1.06M |
| Q1 2021 | share | Increase | +36.18% | 301.8K shares | 46.96M | $214.89 | 1.13M |
| Q4 2020 | share | Increase | +25.22% | 168K shares | 15.87M | $236.34 | 834.1K |
| Q3 2020 | share | 0.00% | 0 shares | -12.11M | $272.12 | 666.1K | |
| Q2 2020 | share | Decrease | -9.67% | -71.3K shares | 17.91M | $290.31 | 666.1K |
| Q1 2020 | share | Decrease | -5.84% | -45.7K shares | 4.00M | $237.95 | 737.4K |
| Q4 2019 | share | Decrease | -7.48% | -63.3K shares | 28.06M | $218.95 | 783.1K |
| Q3 2019 | share | Decrease | -13.04% | -126.9K shares | -35.08M | $169.42 | 846.4K |
| Q2 2019 | share | Increase | +1.88% | 18K shares | 2.75M | $183.38 | 973.3K |
| Q1 2019 | share | Decrease | -15.70% | -177.9K shares | -12.05M | $183.95 | 955.3K |
| Q4 2018 | share | Decrease | -29.20% | -467.3K shares | -120.69M | $165.71 | 1.13M |
| Q4 2018 | call | Decrease | -100.00% | -100K shares | -19.27M | $165.71 | 0 |
| Q3 2018 | call | Decrease | -42.86% | -75K shares | -10.46M | $192.74 | 100K |
| Q3 2018 | share | Decrease | -10.72% | -192.1K shares | 3.81M | $192.74 | 1.60M |
| Q2 2018 | call | Increase | 0.00% | 175K shares | 29.74M | $169.96 | 175K |
| Q2 2018 | share | Decrease | -3.34% | -62K shares | 2.40M | $169.96 | 1.79M |
| Q1 2018 | share | Increase | +6.51% | 113.3K shares | 41.31M | $162.98 | 1.85M |
| Q4 2017 | share | Decrease | -16.05% | -333.00K shares | -54.42M | $149.86 | 1.74M |
| Q3 2017 | share | Increase | +2.36% | 47.8K shares | 54.22M | $152.04 | 2.07M |
| Q2 2017 | share | Decrease | -6.58% | -142.69K shares | 23.95M | $128.87 | 2.02M |
| Q1 2017 | share | Increase | +0.45% | 9.8K shares | 78.11M | $109.35 | 2.16M |
| Q4 2016 | share | Increase | +33.96% | 547.4K shares | 18.5M | $73.67 | 2.15M |
| Q3 2016 | share | Decrease | -26.37% | -577.3K shares | -47.74M | $87.21 | 1.61M |
| Q2 2016 | share | Increase | +17.11% | 319.9K shares | 39.72M | $86.02 | 2.18M |
| Q1 2016 | share | Increase | +177.77% | 1.19M shares | 63.91M | $79.49 | 1.86M |